Drug Profile
Research programme: gene-activated follicle-stimulating hormone - Takeda
Alternative Names: Follicle-stimulating hormone - Takeda; FSH - Takeda; GA-FSH; Gene-activated follicle-stimulating hormone; Gene-activated FSHLatest Information Update: 16 Jan 2019
Price :
$50
*
At a glance
- Originator Shire Pharmaceuticals Group
- Class Follicle stimulating hormones; Pituitary gonadotropins
- Mechanism of Action Ovarian follicle stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Female infertility
Most Recent Events
- 08 Jan 2019 Shire has been acquired and merged into Takeda
- 10 May 2006 Discontinued - Preclinical for Female infertility in USA (Parenteral)
- 28 Jul 2005 Transkaryotic Therapies has been acquired and merged into Shire Pharmaceuticals Group